Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review

Dave Singh*, Mei Lan K. Han, Nathaniel M. Hawkins, John R. Hurst, Janwillem W.H. Kocks, Neil Skolnik, Daiana Stolz, Jad El Khoury, Chris P. Gale

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)
30 Downloads (Pure)

Abstract

Chronic obstructive pulmonary disease (COPD) constitutes a major global health burden and is the third leading cause of death worldwide. A high proportion of patients with COPD have cardiovascular disease, but there is also evidence that COPD is a risk factor for adverse outcomes in cardiovascular disease. Patients with COPD frequently die of respiratory and cardiovascular causes, yet the identification and management of cardiopulmonary risk remain suboptimal owing to limited awareness and clinical intervention. Acute exacerbations punctuate the progression of COPD in many patients, reducing lung function and increasing the risk of subsequent exacerbations and cardiovascular events that may lead to early death. This narrative review defines and summarises the principles of COPD-associated cardiopulmonary risk, and examines respiratory interventions currently available to modify this risk, as well as providing expert opinion on future approaches to addressing cardiopulmonary risk.

Original languageEnglish
Pages (from-to)2151-2167
Number of pages17
JournalAdvances in therapy
Volume41
Issue number6
DOIs
Publication statusPublished - Jun-2024

Keywords

  • Cardiopulmonary risk
  • Cardiovascular disease
  • Chronic obstructive pulmonary disease
  • Exacerbation
  • Inhaled therapy
  • Mortality

Fingerprint

Dive into the research topics of 'Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review'. Together they form a unique fingerprint.

Cite this